4//SEC Filing
EYEGATE PHARMACEUTICALS INC 4
Accession 0001144204-16-113611
$KPRXCIK 0001372514operating
Filed
Jul 18, 8:00 PM ET
Accepted
Jul 19, 5:49 PM ET
Size
5.6 KB
Accession
0001144204-16-113611
Insider Transaction Report
Form 4
Brenneman Ryan Randall
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2016-07-18+4,568→ 4,568 totalExercise: $2.42Exp: 2026-07-18→ Common Stock (4,568 underlying)
Footnotes (1)
- [F1]The Reporting Person received an Option to purchase Common Stock from the Issuer pursuant to the Issuer's 2014 Equity Incentive Plan. The Option will become exercisable as to one-third (1/3) of the shares underlying the Option on July 18, 2017, and the remaining balance vests monthly on the first day of each calendar month thereafter for a period of two years.
Documents
Issuer
EYEGATE PHARMACEUTICALS INC
CIK 0001372514
Entity typeoperating
Related Parties
1- filerCIK 0001372514
Filing Metadata
- Form type
- 4
- Filed
- Jul 18, 8:00 PM ET
- Accepted
- Jul 19, 5:49 PM ET
- Size
- 5.6 KB